Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1991 1
1993 2
1995 3
1996 4
1997 2
1998 2
1999 2
2000 1
2002 3
2004 3
2005 1
2006 1
2007 1
2009 5
2011 2
2012 5
2013 6
2014 4
2015 6
2016 3
2017 6
2018 6
2019 4
2020 8
2021 2
2022 8
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for the time beaugerie
Search for Théotime Beguerie instead (2 results)
Predicting, Preventing, and Managing Treatment-Related Complications in Patients With Inflammatory Bowel Diseases.
Beaugerie L, Rahier JF, Kirchgesner J. Beaugerie L, et al. Clin Gastroenterol Hepatol. 2020 May;18(6):1324-1335.e2. doi: 10.1016/j.cgh.2020.02.009. Epub 2020 Feb 12. Clin Gastroenterol Hepatol. 2020. PMID: 32059920 Free article. Review.
Patients with IBD frequently develop serious infections resulting from the disease itself or its treatment. At the time of diagnosis, patients' vaccination calendars should be updated according to IBD guidelines-live vaccines should be postponed for patients receiving immu …
Patients with IBD frequently develop serious infections resulting from the disease itself or its treatment. At the time of diagnosis, …
Large-scale sequencing identifies multiple genes and rare variants associated with Crohn's disease susceptibility.
Sazonovs A, Stevens CR, Venkataraman GR, Yuan K, Avila B, Abreu MT, Ahmad T, Allez M, Ananthakrishnan AN, Atzmon G, Baras A, Barrett JC, Barzilai N, Beaugerie L, Beecham A, Bernstein CN, Bitton A, Bokemeyer B, Chan A, Chung D, Cleynen I, Cosnes J, Cutler DJ, Daly A, Damas OM, Datta LW, Dawany N, Devoto M, Dodge S, Ellinghaus E, Fachal L, Farkkila M, Faubion W, Ferreira M, Franchimont D, Gabriel SB, Ge T, Georges M, Gettler K, Giri M, Glaser B, Goerg S, Goyette P, Graham D, Hämäläinen E, Haritunians T, Heap GA, Hiltunen M, Hoeppner M, Horowitz JE, Irving P, Iyer V, Jalas C, Kelsen J, Khalili H, Kirschner BS, Kontula K, Koskela JT, Kugathasan S, Kupcinskas J, Lamb CA, Laudes M, Lévesque C, Levine AP, Lewis JD, Liefferinckx C, Loescher BS, Louis E, Mansfield J, May S, McCauley JL, Mengesha E, Mni M, Moayyedi P, Moran CJ, Newberry RD, O'Charoen S, Okou DT, Oldenburg B, Ostrer H, Palotie A, Paquette J, Pekow J, Peter I, Pierik MJ, Ponsioen CY, Pontikos N, Prescott N, Pulver AE, Rahmouni S, Rice DL, Saavalainen P, Sands B, Sartor RB, Schiff ER, Schreiber S, Schumm LP, Segal AW, Seksik P, Shawky R, Sheikh SZ, Silverberg MS, Simmons A, Skeiceviciene J, Sokol H, Solomonson M, Somineni H, S… See abstract for full author list ➔ Sazonovs A, et al. Nat Genet. 2022 Sep;54(9):1275-1283. doi: 10.1038/s41588-022-01156-2. Epub 2022 Aug 29. Nat Genet. 2022. PMID: 36038634 Free PMC article.
We directly implicate ten genes in general onset CD for the first time to our knowledge via association to coding variation, four of which lie within established CD GWAS loci. ...
We directly implicate ten genes in general onset CD for the first time to our knowledge via association to coding variation, four of …
Clinical predictors of aggressive/disabling disease: ulcerative colitis and crohn disease.
Blonski W, Buchner AM, Lichtenstein GR. Blonski W, et al. Gastroenterol Clin North Am. 2012 Jun;41(2):443-62. doi: 10.1016/j.gtc.2012.01.008. Gastroenterol Clin North Am. 2012. PMID: 22500528 Review.
Only two studies analyzed predictors using the same definition of aggressive disease. Only Beaugerie and colleagues developed the score predictive of disabling disease based on three independent factors associated with disabling course that were present at the time …
Only two studies analyzed predictors using the same definition of aggressive disease. Only Beaugerie and colleagues developed the sco …
Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study.
Bouhnik Y, Carbonnel F, Laharie D, Stefanescu C, Hébuterne X, Abitbol V, Nachury M, Brixi H, Bourreille A, Picon L, Bourrier A, Allez M, Peyrin-Biroulet L, Moreau J, Savoye G, Fumery M, Nancey S, Roblin X, Altwegg R, Bouguen G, Bommelaer G, Danese S, Louis E, Zappa M, Mary JY; GETAID CREOLE Study Group. Bouhnik Y, et al. Gut. 2018 Jan;67(1):53-60. doi: 10.1136/gutjnl-2016-312581. Epub 2017 Jan 24. Gut. 2018. PMID: 28119352 Free PMC article.
Secondary endpoints were prolonged success after week 24 (still on adalimumab, without dilation nor surgery) and time to bowel resection in the whole cohort. RESULTS: From January 2010 to December 2011, 105 patients were screened and 97 were included. ...The prognostic sco …
Secondary endpoints were prolonged success after week 24 (still on adalimumab, without dilation nor surgery) and time to bowel resect …
[Refractory proctitis].
Seksik P, Daniel F, Marteau P, Beaugerie L, Cosnes J. Seksik P, et al. Gastroenterol Clin Biol. 2007 Apr;31(4):393-7. doi: 10.1016/s0399-8320(07)89398-5. Gastroenterol Clin Biol. 2007. PMID: 17483776 Free article. Review. French. No abstract available.
Dynamic Prediction of Advanced Colorectal Neoplasia in Inflammatory Bowel Disease.
Wijnands AM, Penning de Vries BBL, Lutgens MWMD, Bakhshi Z, Al Bakir I, Beaugerie L, Bernstein CN, Chang-Ho Choi R, Coelho-Prabhu N, Graham TA, Hart AL, Ten Hove JR, Itzkowitz SH, Kirchgesner J, Mooiweer E, Shaffer SR, Shah SC, Elias SG, Oldenburg B; Dutch Initiative on Crohn and Colitis (ICC). Wijnands AM, et al. Clin Gastroenterol Hepatol. 2024 Feb 29:S1542-3565(24)00214-3. doi: 10.1016/j.cgh.2024.02.014. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 38431223 Free article.
RESULTS: The surveillance cohorts comprised 3731 patients, enrolled and followed-up in the time period from 1973 to 2021, with a median follow-up period of 5.7 years (26,336 patient-years of follow-up evaluation); 146 individuals were diagnosed with aCRN. ...
RESULTS: The surveillance cohorts comprised 3731 patients, enrolled and followed-up in the time period from 1973 to 2021, with a medi …
Noncolorectal malignancies in inflammatory bowel disease: more than meets the eye.
Beaugerie L, Sokol H, Seksik P. Beaugerie L, et al. Dig Dis. 2009;27(3):375-81. doi: 10.1159/000228577. Epub 2009 Sep 24. Dig Dis. 2009. PMID: 19786768 Review.
However, contrasting with the established endoscopic detection of colonic advanced neoplasias in patients with longstanding extensive colitis, there is no consensus at this time how to face the excess-risk of small bowel adenocarcinoma in patients at high risk. ...
However, contrasting with the established endoscopic detection of colonic advanced neoplasias in patients with longstanding extensive coliti …
Changes in the Lémann Index Values During the First Years of Crohn's Disease.
Gilletta C, Lewin M, Bourrier A, Nion-Larmurier I, Rajca S, Beaugerie L, Sokol H, Pariente B, Seksik P, Cosnes J. Gilletta C, et al. Clin Gastroenterol Hepatol. 2015 Sep;13(9):1633-40.e3. doi: 10.1016/j.cgh.2015.02.041. Epub 2015 Mar 10. Clin Gastroenterol Hepatol. 2015. PMID: 25766650
BACKGROUND & AIMS: Stricturing or penetrating lesions develop over time in most patients with Crohn's disease. The Lemann Index indicates the degree of digestive damage at a given time in an individual. ...The only early factor that predicted later damage was th …
BACKGROUND & AIMS: Stricturing or penetrating lesions develop over time in most patients with Crohn's disease. The Lemann Index i …
Thiopurines and myeloid disorders: is more caution needed when treating inflammatory bowel disease patients?
Lopez A, Beaugerie L, Peyrin-Biroulet L. Lopez A, et al. Expert Rev Clin Immunol. 2014 Dec;10(12):1563-5. doi: 10.1586/1744666X.2014.977261. Epub 2014 Nov 1. Expert Rev Clin Immunol. 2014. PMID: 25362886
However, these drugs have potential mutagenic and carcinogenic effects, especially when prescribed for a long time. In addition to the increased risk of lymphoma and non-melanoma skin cancer, recent data suggest that risk of myeloid disorder is increased in IBD patients wi …
However, these drugs have potential mutagenic and carcinogenic effects, especially when prescribed for a long time. In addition to th …
Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process.
Peyrin-Biroulet L, Billioud V, D'Haens G, Panaccione R, Feagan B, Panés J, Danese S, Schreiber S, Ogata H, Hibi T, Higgins PD, Beaugerie L, Chowers Y, Louis E, Steinwurz F, Reinisch W, Rutgeerts P, Colombel JF, Travis S, Sandborn WJ. Peyrin-Biroulet L, et al. Am J Gastroenterol. 2012 Dec;107(12):1770-6. doi: 10.1038/ajg.2012.117. Am J Gastroenterol. 2012. PMID: 23211844
81 results